|
GMNN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.02109999999822E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96043999999285E-05 |
| Normal-vs-Stage2 |
4.66759999995237E-06 |
| Normal-vs-Stage3 |
1.09719999996649E-06 |
| Normal-vs-Stage4 |
1.02989999972714E-07 |
| Stage1-vs-Stage2 |
2.534600E-01 |
| Stage1-vs-Stage3 |
1.584630E-01 |
| Stage1-vs-Stage4 |
1.498220E-02 |
| Stage2-vs-Stage3 |
9.346600E-01 |
| Stage2-vs-Stage4 |
3.092600E-01 |
| Stage3-vs-Stage4 |
2.179000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.07899999999017E-06 |
| Normal-vs-AfricanAmerican |
4.716200E-03 |
| Normal-vs-Asian |
6.3124000004855E-07 |
| Caucasian-vs-AfricanAmerican |
8.744000E-01 |
| Caucasian-vs-Asian |
1.446420E-01 |
| AfricanAmerican-vs-Asian |
3.801200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.67469999998471E-06 |
| Normal-vs-Female |
9.73539999948869E-07 |
| Male-vs-Female |
7.725000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.60250000000151E-05 |
| Normal-vs-Age(41-60Yrs) |
2.36290000010797E-07 |
| Normal-vs-Age(61-80Yrs) |
6.4310000003065E-07 |
| Normal-vs-Age(81-100Yrs) |
5.019700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.237800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.397900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.873000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.148600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.842400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.958800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.117400E-01 |
| Classical-VS-Follicular |
6.788600E-01 |
| Classical-VS-Other |
7.662000E-01 |
| Classical-VS-Normal |
3.97740000002145E-06 |
| Tall-VS-Follicular |
2.259200E-01 |
| Tall-VS-Other |
2.479000E-01 |
| Tall-VS-Normal |
4.80620000020693E-07 |
| Follicular-VS-Other |
7.107400E-01 |
| Follicular-VS-Normal |
3.63319999996392E-06 |
| Other-VS-Normal |
9.826200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.59129999954821E-07 |
| Normal-vs-N1 |
1.69151999999118E-05 |
| N0-vs-N1 |
5.648200E-01 |
|
|
